Production of tumour necrosis factor-alpha, interferon-gamma and interleukin-2 by peripheral blood mononuclear cells of subjects suffering from rheumatoid arthritis
[en] Using radio-immunoassay methods, the production of tumour necrosis factor-alpha (TNF-alpha), interleukin-2 (IL-2), and interferon-gamma (IFN-gamma) released by peripheral blood mononuclear cells (PBMC), maintained in culture and stimulated by phytohemagglutinin (PHA), was measured in normal subjects and patients with active or inactive rheumatoid arthritis (RA). Results indicated a dissociation between mitogenic response and secretion of mediators by PBMC under the influence of PHA in both normal controls and in patients with rheumatoid arthritis (RA). While [3H]thymidine incorporation was characterized by a rather bell-shaped curve with increasing concentrations of PHA, IL-2 and TNF-alpha displayed a linear dose-dependent increase. [3H]thymidine uptake by PBMC was in the same range in normal subjects as in patients with active and inactive RA, although cytokine secretion differed. The PBMC of patients with active RA produced less TNF-alpha, IL-2, and IFN-gamma than did those of the controls. In cases of inactive RA, the secretory response varied from subject to subject; mean values did not differ from those of normal subjects, except for those of IL-2 (p less than 0.01). The significance and the clinical relevance of these findings are discussed.
Production of tumour necrosis factor-alpha, interferon-gamma and interleukin-2 by peripheral blood mononuclear cells of subjects suffering from rheumatoid arthritis
Depper J.M., Bluestein H.G., Zvaifler N.J. (1981) Impaired regulation of Epstein-Barr virus-induced lymphocyte proliferation in rheumatoid arthritis is due to a T cell defect. J Immunol 127:1899-1902.
Strelkauskas A.J., Callery R.T., McDowell J., Borel Y., Schlossman S.F. (1978) Direct evidence for loss of human suppressor cells during active autoimmune disease. Proc Natl Acad Sci USA 75:5150-5154.
Tosato G., Steinberg A.D., Blaese R.M. (1981) Defective EBV specific T-cell function in rheumatoid arthritis. N Engl J Med 305:1238-1243.
Al-Balaghi S., Strom H., Moller E. (1984) B-cell differentiation factor in synovial fluids of patients with rheumatoid arthritis. Immunol Rev 78:7-23.
Pardo I., Levinson A.I. (1983) Circulating immunoglobulin secreting cells in rheumatoid arthritis. Clin Immunol Immunopathol 29:29-34.
Krane S.M., Simon L.S. (1986) Rheumatoid arthritis: clinical features and pathogenetic mechanisms. Med Clin North Am 70:263-284.
Gillis S., Ferm M.M., Ou W., Smith K.A. (1978) T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 120:2027-2032.
Atkins G.J., Johnson M.D., Westmacott L.M., Burke D.C. (1974) Induction of interferon in chick cells by temperature-sensitive mutants of sindbis virus. J Gen Virol 25:381-390.
Yamazaki S., Onishi E., Enami K., Natori K., Kohase M., Sakamoto H., Tanouchi M., Hayashi H. (1986) Proposal of standardized methods and reference for assaying recombinant human tumor necrosis factor. Japan J Med Sci Biol 39:105-118.
Ropes M.W., Bennett E.A., Cobb S., Jacox R., Jessar R. (1958) Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9:175-176.
Tice R.R., Schneider E.L., Kram D., Thorne P. (1979) Cytokinetic analysis of the impaired proliferative response of peripheral lymphocytes from aged humans to phytohemagglutinin. J Exp Med 149:1029-1041.
Greenwood F., Hunter W., Glover J. (1963) The preparation of 131I-labelled human growth hormone of high specific radioactivity. Biochem J 89:114-124.
Franchimont P., Bouffioux C.H., Reuter A., Rigo-Betz C.H., Vrindts-Gevaert Y., Jaspar J.M., Lecomte-Yerna M.J. (1983) Radioimmunoassay of prostatic acid phosphatase: validation and clinical application. Int J Cancer 1:149-155.
Reuter A., Bernier J., Vrindts-Gevaert Y., Gathy-Meuleman R., Malaise M., Fiers W., Franchimont P. Radioimmunoassay of interferon-gamma. Its clinical application, Interferon Research [in press].; .
Cathely G., Dougados B., Amor B., Fradelizi D. (1984) Interleukine 2 et polyarthrite rhumatoi'de. Rev Rhum 51:251-256.
McKenna R.M., Ofosu-Appiah W., Warrington R.J., Wilkins J.A. (1986) Interleukin-2 production and responsiveness in active and inactive rheumatoid arthritis. J Rheumatol 13:28-33.
Miyasaka N., Nakamura T., Russell I.J., Talal N. (1984) Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin Immunol Immunopathol 31:109-116.
Lemm G., Warnatz H. (1986) Evidence for enhanced interleukin 2 (IL2) secretion and IL2 receptor presentation by synovial fluid lymphocytes in rheumatoid arthritis. Clin Exp Immunol 64:71-77.
Ridley M.G., Panayi G.S., Nicholas N.S., Murphy J. (1986) Mechanisms of macrophage activation in rheumatoid arthritis: the role of gamma interferon. Clin Exp Immunol 63:587-593.
Combe B., Pope R.M., Fishbach L.M., Dennell B., Baron S., Talal N. (1985) Interleukin 2 in rheumatoid arthritis: production of and response to interleukin 2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol 59:520-531.
Hasler F., Bluestein H.G., Zvaifler N.J., Epstein L.B. (1983) Analysis of the defect responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma-interferon production in response to autologous stimulation. J Exp Med 157:173-181.
Tsokos G.C., Boumpas D.R., Smith J.Y., Djeu S.M.Y., Balow J.E., Rook A.H. (1986) Deficient gamma-interferon production in patients with systemic lupus erythematosus. Arthritis Rheum 29:1210-1215.
Ceuppens J.L., Robaeys G., Verdickt W., Vertessen S., Deckmyn H., Dequeker J. (1986) Immunomodulatory effects of treatment with Naproxen in patients with rheumatic disease. Arthritis Rheum 29:305-311.
Rola-Pleszczynski M., Chavailiaz P.A., Lemaire I. (1986) Stimulation of interleukin 2 and interferon gamma production by leukotriene B4 in human lymphocyte cultures. Prostaglandins Leukotrienes Med 23:207-210.
Cathely G., Amor B., Fournier C. (1986) Defective IL2 production in active rheumatoid arthritis. Regulation by radiosensitive suppressor cells. Clin Rheumatol 5:482-492.
Kass E., Waalen K., Forre O. (1987) Rheumatoid synovial T cells are activated in vivo. Inhibition of the spontaneous interleukin 2-driven proliferation by anti-Tac and cyclosporin. Clin Exp Rheuma 5:58.